Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials (ELMs), enabling more precise control over their structure and how they respond to deformation forces like stretching or compression.
Eli Lilly reveals two-year data for experimental eczema treatment after FDA roadblock
Eli Lilly is bolstering the case for its experimental eczema treatment lebrikizumab with a first look at how patients fared after two years of maintenance
October 21, 2023